We offer a wide range of trusted, precise, and accurate immunoassays services
Enzyme-linked immunosorbent assays (ELISAs) are a proven gene therapy technology. Noble can be your trusted partner for all ELISA cell and gene therapies that are required for your emerging therapy.
ELISAs are able to deliver precise, quantitative antibody-based measurements for cell and gene targets for which there is a sensitive and specific binding reagent.
Noble offers ELISA development services to support pre-clinical through phase 3 studies, including assay development or transfer, validation, and implementation.
Whether your therapy needs require ELISA services for cytokines and chemokines or flow cytometry and specific immune cell analysis, Noble’s professional lab scientists are able to provide a wide range of trusted, precise and accurate cell and gene therapy immunoassays services that can be customized for your specific testing and data collection needs.
- Enzyme-linked immunosorbent assays (ELISA)
- ELISA for Cytokines and chemokines
- Flow Cytometry
- Antigen-specific CD8 T cells in Splenocytes
- Specific immune cell analysis in PBMC and Spleen
- Antibody titering by ELISA (this is not for Oncology)
Explore other areas of expertise
How Our Team Can Help
With decades of GLP experience, our scientists can support all aspects of the GLP process, from design to regulatory support of your IND, IDE, or PMA FDA submission.
Arundhati Ghosh, Ph.D., MSc
Pang-Kuo Lo, Ph.D. MSc
Team Lead, Assay Development
Todd Parsley, Ph.D.
Director, Infectious Diseases